24-09-2026 17:45 via wallstreet-online.de

IRLAB Appoints Janne Backman as New Chairman of the Board

IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, announces that Jan-Fredrik ("Janne") Backman today assumes the role of Chairman of the Board. He was elected Vice …
Weiterlesen »